Table 1.

Drug-specific indicators extracted from the rapid literature review for the APs included in this study.

Drug	Indicators specific for each of the selected drugs
Haloperidol	Aged 65 or older Renal function Hepatic function Comorbidities EKG Concomitant medication Electrolyte disturbances (especially with potassium and magnesium)
Olanzapine/risperidone	Aged 65 or older Renal function Hepatic function Comorbidities EKG Hyperglycaemia/diabetes mellitus BMI > 30 kg/m2 Hypercholesterolemia High risk for metabolic syndrome High cardiovascular risk
Quetiapine	Aged 65 or older Renal function Hepatic function Comorbidities EKG Blood pressure High cardiovascular risk High risk for metabolic syndrome Hyperglycaemia/diabetes mellitus Hypercholesterolemia
Aripiprazole	Aged 65 or older Renal function Hepatic function EKG Sex Smoking habits High cardiovascular risk Hyperglycaemia/diabetes mellitus BMI > 30 kg/m2

BMI, Body Mass Index; EKG, electrocardiogram.